Jessalyn Ubellacker, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Cells | 4 | 2023 | 2414 | 0.740 |
Why?
|
| Lymph | 1 | 2020 | 78 | 0.700 |
Why?
|
| Neoplasm Metastasis | 3 | 2023 | 4912 | 0.650 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 356 | 0.470 |
Why?
|
| Receptors, Leptin | 3 | 2025 | 352 | 0.450 |
Why?
|
| Diphosphonates | 1 | 2017 | 634 | 0.390 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2023 | 3409 | 0.380 |
Why?
|
| Hematopoiesis | 2 | 2018 | 2059 | 0.370 |
Why?
|
| Imidazoles | 1 | 2017 | 1169 | 0.360 |
Why?
|
| Cell Lineage | 2 | 2018 | 2575 | 0.340 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 797 | 0.330 |
Why?
|
| Melanoma | 3 | 2023 | 5706 | 0.290 |
Why?
|
| Breast Neoplasms | 6 | 2023 | 21206 | 0.280 |
Why?
|
| Bone Marrow | 3 | 2023 | 2935 | 0.250 |
Why?
|
| Lymphatic Metastasis | 3 | 2024 | 2914 | 0.250 |
Why?
|
| Osteoclasts | 2 | 2018 | 713 | 0.220 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3948 | 0.210 |
Why?
|
| Metabolomics | 2 | 2022 | 1674 | 0.200 |
Why?
|
| Neoadjuvant Therapy | 2 | 2023 | 2907 | 0.190 |
Why?
|
| Stromal Cells | 2 | 2025 | 1336 | 0.190 |
Why?
|
| Electron Transport Complex I | 1 | 2022 | 152 | 0.190 |
Why?
|
| Coenzyme A Ligases | 1 | 2020 | 45 | 0.180 |
Why?
|
| Oleic Acid | 1 | 2020 | 91 | 0.170 |
Why?
|
| Lymphopoiesis | 1 | 2021 | 133 | 0.170 |
Why?
|
| Arterioles | 1 | 2021 | 251 | 0.170 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2019 | 81 | 0.170 |
Why?
|
| Xanthones | 1 | 2019 | 23 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5863 | 0.160 |
Why?
|
| Glutamine | 1 | 2022 | 577 | 0.160 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 17140 | 0.150 |
Why?
|
| Interferons | 2 | 2019 | 720 | 0.150 |
Why?
|
| Glutathione | 1 | 2020 | 589 | 0.150 |
Why?
|
| Lymph Nodes | 4 | 2024 | 3474 | 0.150 |
Why?
|
| Mice, Nude | 3 | 2018 | 3623 | 0.150 |
Why?
|
| Lymphangiogenesis | 1 | 2019 | 171 | 0.150 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 347 | 0.140 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 948 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 996 | 0.140 |
Why?
|
| Symporters | 1 | 2019 | 363 | 0.140 |
Why?
|
| Colony-Forming Units Assay | 1 | 2017 | 351 | 0.140 |
Why?
|
| Mice | 13 | 2025 | 82029 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2018 | 631 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2021 | 3139 | 0.120 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 457 | 0.120 |
Why?
|
| Bone and Bones | 3 | 2025 | 2589 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2017 | 354 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2021 | 1288 | 0.110 |
Why?
|
| Metabolome | 1 | 2021 | 1009 | 0.110 |
Why?
|
| Neoplasms | 4 | 2024 | 22371 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2017 | 565 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 2202 | 0.110 |
Why?
|
| Cell Survival | 2 | 2020 | 5777 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2018 | 839 | 0.110 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1609 | 0.100 |
Why?
|
| Animals | 15 | 2025 | 169246 | 0.100 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1120 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 1027 | 0.100 |
Why?
|
| Ovarian Diseases | 1 | 2013 | 136 | 0.100 |
Why?
|
| Iron | 1 | 2020 | 1813 | 0.100 |
Why?
|
| Osteoblasts | 1 | 2017 | 1145 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2013 | 271 | 0.090 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2013 | 221 | 0.090 |
Why?
|
| Axilla | 2 | 2023 | 623 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3160 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4352 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2018 | 11669 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2013 | 467 | 0.080 |
Why?
|
| Ovarian Cysts | 1 | 2010 | 108 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2023 | 3986 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1738 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2018 | 1985 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 2631 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2019 | 3611 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 22379 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 2565 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2023 | 3556 | 0.060 |
Why?
|
| Humans | 20 | 2024 | 768166 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18349 | 0.050 |
Why?
|
| Female | 12 | 2023 | 397192 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2018 | 12800 | 0.050 |
Why?
|
| Macrophages | 1 | 2018 | 5799 | 0.050 |
Why?
|
| Inflammation | 2 | 2023 | 10873 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2024 | 251 | 0.050 |
Why?
|
| Antigen Presentation | 2 | 2019 | 1251 | 0.050 |
Why?
|
| Isotopes | 1 | 2022 | 125 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2023 | 156 | 0.050 |
Why?
|
| Ceramides | 1 | 2023 | 203 | 0.050 |
Why?
|
| Electron Transport | 1 | 2022 | 211 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2747 | 0.050 |
Why?
|
| Tumor Escape | 1 | 2024 | 372 | 0.050 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2021 | 98 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5703 | 0.050 |
Why?
|
| Stem Cell Factor | 1 | 2021 | 194 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9419 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 393 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4793 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2025 | 1972 | 0.040 |
Why?
|
| NAD | 1 | 2022 | 618 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2023 | 797 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2021 | 594 | 0.040 |
Why?
|
| Lymph Node Excision | 1 | 2023 | 1271 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10474 | 0.030 |
Why?
|
| RNA, Double-Stranded | 1 | 2017 | 292 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13676 | 0.030 |
Why?
|
| Signal Transduction | 4 | 2019 | 23645 | 0.030 |
Why?
|
| Breast | 1 | 2023 | 1976 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2300 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13586 | 0.030 |
Why?
|
| Cadherins | 1 | 2018 | 905 | 0.030 |
Why?
|
| Kentucky | 1 | 2013 | 83 | 0.030 |
Why?
|
| Viruses | 1 | 2017 | 373 | 0.030 |
Why?
|
| Antioxidants | 1 | 2021 | 1673 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2149 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 4916 | 0.030 |
Why?
|
| Aging | 2 | 2023 | 8744 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2022 | 1839 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2021 | 2614 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1196 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11878 | 0.030 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 246 | 0.020 |
Why?
|
| Erythroid Cells | 1 | 2013 | 237 | 0.020 |
Why?
|
| Carbazoles | 1 | 2013 | 230 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 4063 | 0.020 |
Why?
|
| Cell Communication | 1 | 2018 | 1660 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.020 |
Why?
|
| Transfection | 1 | 2018 | 5755 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5902 | 0.020 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2010 | 62 | 0.020 |
Why?
|
| Male | 4 | 2021 | 364719 | 0.020 |
Why?
|
| Apoptosis | 2 | 2018 | 9523 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 2457 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6231 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2018 | 2885 | 0.020 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 572 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2021 | 3329 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 1805 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2013 | 571 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1169 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2013 | 6004 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2024 | 4755 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4035 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3343 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2017 | 2982 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2017 | 8317 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 480 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 3114 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18412 | 0.010 |
Why?
|
| Endometriosis | 1 | 2010 | 873 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1887 | 0.010 |
Why?
|
| Genome, Human | 1 | 2013 | 4446 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14488 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15454 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40218 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 59629 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15869 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11101 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21538 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16726 | 0.010 |
Why?
|
| Mass Screening | 1 | 2010 | 5458 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 171504 | 0.000 |
Why?
|
| Mutation | 1 | 2013 | 30238 | 0.000 |
Why?
|
| Middle Aged | 2 | 2013 | 223492 | 0.000 |
Why?
|
| Adult | 2 | 2013 | 223646 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74944 | 0.000 |
Why?
|
| United States | 1 | 2010 | 73039 | 0.000 |
Why?
|